PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366J900. A total of 5 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $165,132 | +1035.3% | 5,400 | +980.0% | 0.00% | – |
Q1 2024 | $14,545 | -90.2% | 500 | -90.7% | 0.00% | – |
Q4 2023 | $148,824 | -20.0% | 5,400 | -34.9% | 0.00% | -100.0% |
Q3 2023 | $186,003 | -89.0% | 8,300 | -80.1% | 0.00% | -80.0% |
Q2 2023 | $1,695,939 | +55.6% | 41,700 | +85.3% | 0.01% | +25.0% |
Q1 2023 | $1,089,900 | +3469.2% | 22,500 | +2712.5% | 0.00% | – |
Q4 2022 | $30,536 | -12.8% | 800 | +14.3% | 0.00% | – |
Q3 2022 | $35,000 | -81.6% | 700 | -86.3% | 0.00% | – |
Q1 2022 | $190,000 | – | 5,100 | +5000.0% | 0.00% | – |
Q4 2021 | $0 | -100.0% | 100 | -83.3% | 0.00% | – |
Q3 2021 | $22,000 | +29.4% | 600 | +50.0% | 0.00% | – |
Q2 2021 | $17,000 | -98.5% | 400 | -98.4% | 0.00% | -100.0% |
Q1 2021 | $1,160,000 | -50.9% | 24,500 | -36.7% | 0.00% | -50.0% |
Q4 2020 | $2,362,000 | +109.6% | 38,700 | +60.6% | 0.00% | 0.0% |
Q3 2020 | $1,127,000 | -74.8% | 24,100 | -72.7% | 0.00% | -81.0% |
Q2 2020 | $4,475,000 | +406.8% | 88,200 | +345.5% | 0.02% | +200.0% |
Q1 2020 | $883,000 | -86.8% | 19,800 | -85.7% | 0.01% | -84.4% |
Q4 2019 | $6,671,000 | +168.8% | 138,900 | +89.2% | 0.04% | +125.0% |
Q3 2019 | $2,482,000 | +124.2% | 73,400 | +198.4% | 0.02% | +100.0% |
Q2 2019 | $1,107,000 | +143.3% | 24,600 | +103.3% | 0.01% | +100.0% |
Q1 2019 | $455,000 | -4.0% | 12,100 | -12.3% | 0.01% | +25.0% |
Q4 2018 | $474,000 | -38.1% | 13,800 | -15.3% | 0.00% | -33.3% |
Q3 2018 | $766,000 | +68.4% | 16,300 | +20.7% | 0.01% | +50.0% |
Q2 2018 | $455,000 | -49.2% | 13,500 | -59.2% | 0.00% | -55.6% |
Q1 2018 | $896,000 | -31.0% | 33,100 | -57.5% | 0.01% | 0.0% |
Q4 2017 | $1,299,000 | -58.8% | 77,900 | -50.6% | 0.01% | -69.0% |
Q3 2017 | $3,154,000 | +97.5% | 157,600 | +80.9% | 0.03% | +70.6% |
Q2 2017 | $1,597,000 | +58.1% | 87,100 | -15.1% | 0.02% | +41.7% |
Q1 2017 | $1,010,000 | -29.3% | 102,600 | -21.6% | 0.01% | -14.3% |
Q4 2016 | $1,428,000 | -41.9% | 130,900 | -25.4% | 0.01% | -48.1% |
Q3 2016 | $2,457,000 | +571.3% | 175,400 | +236.0% | 0.03% | +575.0% |
Q2 2016 | $366,000 | -42.3% | 52,200 | -47.0% | 0.00% | -55.6% |
Q1 2016 | $634,000 | -82.8% | 98,500 | -13.5% | 0.01% | -79.5% |
Q4 2015 | $3,690,000 | -20.4% | 113,900 | -34.4% | 0.04% | -31.2% |
Q3 2015 | $4,635,000 | +970.4% | 173,600 | +1828.9% | 0.06% | +966.7% |
Q2 2015 | $433,000 | -49.5% | 9,000 | -36.2% | 0.01% | -53.8% |
Q1 2015 | $858,000 | +17060.0% | 14,100 | +14000.0% | 0.01% | – |
Q4 2014 | $5,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 50,000 | $2,230,000 | 0.21% |
GROUP ONE TRADING, L.P. | 19,800 | $883,000 | 0.01% |
SIMPLEX TRADING, LLC | 357 | $1,592,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 17,200 | $767,000 | 0.00% |